return2ozma@lemmy.world to News@lemmy.world · 9 个月前Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square158fedilinkarrow-up1617arrow-down117cross-posted to: anticorporate@lemmy.giftedmc.compiracy@lemmy.dbzer0.comnews@beehaw.orgmedicine@mander.xyz
arrow-up1600arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comreturn2ozma@lemmy.world to News@lemmy.world · 9 个月前message-square158fedilinkcross-posted to: anticorporate@lemmy.giftedmc.compiracy@lemmy.dbzer0.comnews@beehaw.orgmedicine@mander.xyz
minus-squareEnderMB@lemmy.worldlinkfedilinkarrow-up7·9 个月前I’m sure there are some costs associated with developing drugs, and I’m sure it’s not cheap. The problem still stands, though, and the solution is capping executive pay in public companies.
I’m sure there are some costs associated with developing drugs, and I’m sure it’s not cheap.
The problem still stands, though, and the solution is capping executive pay in public companies.